PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.290
+0.040 (3.20%)
Apr 1, 2025, 4:00 PM EDT - Market closed

PharmaCyte Biotech Statistics

Total Valuation

PMCB has a market cap or net worth of $8.89 million. The enterprise value is -$8.14 million.

Market Cap 8.89M
Enterprise Value -8.14M

Important Dates

The last earnings date was Monday, March 17, 2025, after market close.

Earnings Date Mar 17, 2025
Ex-Dividend Date n/a

Share Statistics

PMCB has 6.89 million shares outstanding. The number of shares has decreased by -35.50% in one year.

Current Share Class 6.89M
Shares Outstanding 6.89M
Shares Change (YoY) -35.50%
Shares Change (QoQ) -8.87%
Owned by Insiders (%) 2.84%
Owned by Institutions (%) 11.49%
Float 6.17M

Valuation Ratios

The trailing PE ratio is 0.97.

PE Ratio 0.97
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.21
P/TBV Ratio 0.22
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.20

Current Ratio 14.20
Quick Ratio 14.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 42.89% and return on invested capital (ROIC) is -5.96%.

Return on Equity (ROE) 42.89%
Return on Assets (ROA) -4.89%
Return on Invested Capital (ROIC) -5.96%
Return on Capital Employed (ROCE) -10.56%
Revenue Per Employee n/a
Profits Per Employee $4.99M
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.57% in the last 52 weeks. The beta is -0.53, so PMCB's price volatility has been lower than the market average.

Beta (5Y) -0.53
52-Week Price Change -45.57%
50-Day Moving Average 1.62
200-Day Moving Average 1.76
Relative Strength Index (RSI) 32.32
Average Volume (20 Days) 14,755

Short Selling Information

The latest short interest is 26,759, so 0.39% of the outstanding shares have been sold short.

Short Interest 26,759
Short Previous Month 14,684
Short % of Shares Out 0.39%
Short % of Float 0.43%
Short Ratio (days to cover) 1.17

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -4.50M
Pretax Income -1.14M
Net Income 9.98M
EBITDA n/a
EBIT -4.50M
Earnings Per Share (EPS) $1.29
Full Income Statement

Balance Sheet

The company has $16.76 million in cash and n/a in debt, giving a net cash position of $16.76 million or $2.43 per share.

Cash & Cash Equivalents 16.76M
Total Debt n/a
Net Cash 16.76M
Net Cash Per Share $2.43
Equity (Book Value) 40.25M
Book Value Per Share 5.83
Working Capital 15.77M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.27M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PMCB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 35.50%
Shareholder Yield 35.50%
Earnings Yield 115.80%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on July 12, 2021. It was a reverse split with a ratio of 0.0006667:1.

Last Split Date Jul 12, 2021
Split Type Reverse
Split Ratio 0.0006667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1